Moreover, JMJD6 expression levels are higher in the samples with HRAS and BRAF mutations compared to samples with wild type HRAS and BRAF (Supplementary Figures S4C,D), suggesting that JMJD6 is upregulated by RAS signaling in these melanomas. Here, HRAS is linked to melanoma.